Porphyrins containing nitric oxide donors: Synthesis and cancer cell-oriented NO release

Bioorganic & Medicinal Chemistry Letters
2009.0

Abstract

Four novel porphyrins containing nitric oxide (NO) donors were synthesized, and the structures of all the products were characterized by IR, UV-vis, (1)H NMR, and elementary analysis. Interestingly, these new compounds not only were able to release NO, but also showed cancer cell-oriented accumulation. Higher accumulation of these new porphyrins containing NO donors in BEL-7402 liver cancer cells than in L-02 liver normal cells was corroborated by UV-vis spectroscopy. The biological activity of these porphyrins against BEL-7402 liver cancer cells was tested with a MTT assay. The studies indicated that they had more effective killing of BEL-7402 liver cancer cells than that of L-02 liver normal cells, and they had similar activity against MCF-7 breast cancer cells when compared to 5-fluorouracil in the absence of light.

Knowledge Graph

Similar Paper

Porphyrins containing nitric oxide donors: Synthesis and cancer cell-oriented NO release
Bioorganic & Medicinal Chemistry Letters 2009.0
Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies
European Journal of Medicinal Chemistry 2022.0
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity
ACS Medicinal Chemistry Letters 2011.0
Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Design and Synthesis of 3‘- and 5‘-O-(3-Benzenesulfonylfuroxan-4-yl)-2‘-deoxyuridines:  Biological Evaluation as Hybrid Nitric Oxide Donor−Nucleoside Anticancer Agents
Journal of Medicinal Chemistry 2004.0
Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents
European Journal of Medicinal Chemistry 2017.0
Synthesis of harmine-nitric oxide donor derivatives as potential antitumor agents
Bioorganic & Medicinal Chemistry Letters 2022.0
Synthesis and evaluation of radiolabeled porphyrin derivatives for cancer diagnoses and their nonradioactive counterparts for photodynamic therapy
RSC Medicinal Chemistry 2022.0
Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine
Bioorganic & Medicinal Chemistry 2016.0